Intrauterine perfusion of dexamethasone improves pregnancy outcomes in recurrent reproductive failure patients with elevated uterine natural killer cells. A retrospective cohort study.
Feng ZhangZhuran WangRuochun LianLianghui DiaoYuye LiYaya WuTailang YinChunyu HuangPublished in: American journal of reproductive immunology (New York, N.Y. : 1989) (2023)
Intrauterine perfusion of DXM was a promising and effective treatment to enhance clinical pregnancy rate and live birth rate in RRF women with abnormally elevated uNK cells, and RIF patients are more likely to benefit than RPL patients.
Keyphrases
- end stage renal disease
- pregnancy outcomes
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- pregnant women
- low dose
- magnetic resonance imaging
- induced apoptosis
- natural killer cells
- cell proliferation
- magnetic resonance
- oxidative stress
- endoplasmic reticulum stress
- patient reported
- contrast enhanced
- pulmonary tuberculosis
- gestational age
- cell cycle arrest